This inventor holds 4 USPTO granted patents. Top assignee: University of California. Active years: 2000-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- El Cerrito, CA (US) (2002)
- Berkeley, CA (US) (2000 - 2008)
Company Filing History:
Years Active: 2000-2008
Title: The Innovations of Benito O De Lumen
Introduction
Benito O De Lumen is a notable inventor based in Berkeley, CA. He has made significant contributions to the field of biotechnology, particularly in the area of peptide research. With a total of 4 patents to his name, his work focuses on methods that can selectively disrupt undesirable mitotic functions in various target cells.
Latest Patents
One of his latest patents involves the invention of Lunasin peptides. This invention provides methods and compositions for selectively disrupting mitotic function in target cells that demonstrate undesirable mitotic behavior. The suitable target cells include mammalian, plant, and bacterial cells, which can be in vitro or in situ. The general methods involve introducing an effective amount of a peptide comprising contiguous acidic amino acids, such as Asp or Glu, to selectively disrupt the undesirable mitotic function of the cell. In particular embodiments, the peptide comprises a Gm2S-1 peptide, specifically a lunasin and/or alisin peptide. The peptide may be introduced by transfecting the cell with a nucleic acid encoding the peptide.
Career Highlights
Benito O De Lumen is affiliated with the University of California, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in various fields, including medicine and agriculture.
Collaborations
He has collaborated with Alfredo Flores Galvez, contributing to the development of innovative solutions in biotechnology.
Conclusion
Benito O De Lumen's contributions to the field of peptide research and biotechnology highlight his role as a significant inventor. His innovative methods for disrupting mitotic functions in target cells pave the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
